Skip to main content
KUKJEON PHARMACEUTICAL Co.,Ltd logo

KUKJEON PHARMACEUTICAL Co.,Ltd — Investor Relations & Filings

Ticker · 307750 ISIN · KR7307750000 KO Manufacturing
Open in API
Filings indexed 320 across all filing types
Latest filing 2025-08-19 Major Shareholding Noti…
Country KR South Korea
Listing KO 307750

About KUKJEON PHARMACEUTICAL Co.,Ltd

https://www.kukjeon.co.kr/en/

KUKJEON PHARMACEUTICAL Co., Ltd. is a chemical total solution provider specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs). The company's portfolio includes raw materials for specialized medicines such as choline alfoscerates, benfothiamines, and napamostat. A key product is Itopride hydrochloride, a functional indigestion treatment, for which the company holds a proprietary manufacturing patent. In addition to its pharmaceutical focus, the company also develops and supplies chemical materials for the electronics industry.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in shareholding, and collateral agreements (stock-backed loans) of major shareholders and special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-08-19 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'Kukjeon Pharmaceutical' (국전약품) for the period ending June 30, 2025. It contains detailed financial information, business descriptions, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (stock-backed loans) of major shareholders and their special relations. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-08-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (DART system) used to disclose significant changes in share ownership by major shareholders and their special relations. This specific document details changes in share collateral agreements (stock-backed loans) by the major shareholder and related parties. In the context of global financial reporting, this falls under 'Major Shareholding Notification' (MRQ) as it tracks ownership thresholds and related contractual changes.
2025-07-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details changes in share ownership, specifically related to stock collateral contracts (주식담보대출) by the major shareholder and related parties. In the context of global financial reporting, this falls under the category of 'Major Shareholding Notification' (MRQ), as it tracks significant ownership thresholds and changes in control-related holdings.
2025-07-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in share ownership, and collateral agreements (stock-backed loans) of the major shareholder and related parties of the company 'Kukjeon Pharmaceutical'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-06-20 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.